HealthQuill Treatment
The European Commission has approved AbbVie Inc.’s drug for the treatment of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs.
Drugs Health Pharma

EC approves AbbVie Inc.s drug for a type of juvenile idiopathic arthritis

HQ Team September 22, 2026: The European Commission has approved AbbVie Inc.’s drug for the treatment of active polyarticular juvenile idiopathic arthritis in.

Read More
American pharmaceutical company Johnson & Johnson’s investigational drug met its main goal during end-stage trials for the treatment of manic episodes in adults with bipolar I disorder, according to the company.
Drugs Pharma Research

J&J’s test drug for manic episodes in bipolar disorder meets main goal

HQ Team September 22, 2026: American pharmaceutical company Johnson & Johnson’s investigational drug met its main goal during end-stage trials for the treatment.

Read More
About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World Health Organization.
Drugs Health Pharma

1 person contracts genital herpes infection every second in the world

About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World.

Read More
The size of the human brain is getting larger and the bigger size may reduce the potential of overall age-related dementia, according to a study.
Drugs Health Medical

Researchers identify 6 new biotypes of depression, paving way for better treatment options

HQ Team July 19, 2024:A new study from Stanford has identified six new subtypes of depression known as “biotypes” using brain imaging with.

Read More
The FDA has issued revised draft guidance for early treatment of Alzheimer’s disease with drugmakers told to focus on medicines that are likely to predict a clinical benefit.
Drugs Health Pharma

FDA issues revised drug guidelines for early Alzheimer’s disease

HQ Team March 12, 2024: The FDA has issued revised draft guidance for early treatment of Alzheimer’s disease with drugmakers told to focus.

Read More